Quantessence Capital LLC Gossamer Bio, Inc. Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
A detailed history of Quantessence Capital LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 118,349 shares of GOSS stock, worth $124,266. This represents 0.03% of its overall portfolio holdings.
Number of Shares
118,349Holding current value
$124,266% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
160MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$19.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$19 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$10.6 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$8.46 Million7.27% of portfolio
-
Silverarc Capital Management, LLC6.32MShares$6.64 Million1.69% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $98.7M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...